Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Increased atherosclerosis in streptozotocin-induced diabetic mice.
V V Kunjathoor, … , D L Wilson, R C LeBoeuf
V V Kunjathoor, … , D L Wilson, R C LeBoeuf
Published April 1, 1996
Citation Information: J Clin Invest. 1996;97(7):1767-1773. https://doi.org/10.1172/JCI118604.
View: Text | PDF
Research Article Article has an altmetric score of 4

Increased atherosclerosis in streptozotocin-induced diabetic mice.

  • Text
  • PDF
Abstract

Premature and extensive atheroscleroses involving renal, peripheral, and cardiovascular sites remain major complications of diabetes mellitus. Controversy exists as to the contribution of hyperglycemia versus elevated local or systemic concentrations of insulin to atherosclerosis risk. In this report, we developed the first murine model susceptible to both atherosclerosis and diabetes to determine which diabetogenic factors contribute to vascular disease. C57BL/6 and BALB/c mice were treated with multiple low-dose streptozotocin (STZ) or control citrate buffer and fed rodent chow or an atherogenic-promoting (Ath) diet for 12-20 wk. STZ treatment resulted in sustained hyperglycemia (250-420 mg/dl) and a modest reduction in plasma insulin levels for both strains regardless of diet. Citrate-treated C57BL/6 mice fed the Ath diet showed extensive oil red O-staining fatty streak aortic sinus lesions (20,537+/-2,957 micron2), the size of which did not differ for Ath-fed mice treated with STZ (16,836+/-2,136 micron2). In contrast, hyperglycemic BALB/c mice fed the Ath diet showed a 17-fold increase in atherosclerotic lesion area (7,922+/-2,096 micron2) as compared with citrate-treated mice fed the Ath diet (467+/-318 micron2). Correlations between lesion size and plasma glucose levels were significant for BALB/c (r = 0.741, P < 0.009), but not C57BL/6 (r = 0.314, P<0.3) mice. Lesion size correlated significantly with plasma cholesterol for C57BL/6 (r = 0.612, P<0.03) but not BALB/c (r = 0.630, P<0.1) mice. Immunohistochemistry showed that aortic sinus lesions from both strains contained macrophages, but smooth muscle cells were clearly present in lesions of BALB/c mice. In summary, we present the first small animal model showing accelerated atherosclerosis in response to hyperglycemia. Fatty streaks resembled those of human type II lesions in that both macrophages and smooth muscle cells were evident. In addition, our results support the concept that hyperglycemia as opposed to hyperinsulinemia contributes heavily to risk of atherosclerosis.

Authors

V V Kunjathoor, D L Wilson, R C LeBoeuf

×

Total citations by year

Year: 2025 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Total
Citations: 1 3 3 3 1 4 5 6 9 2 6 2 6 3 4 4 6 5 6 10 6 4 7 8 7 6 3 1 131
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (131)

Title and authors Publication Year
Intravenous D‑allose administration improves blood glucose control by maintaining insulin secretion in diabetic mice with transplanted islets
Noge S, Kumamoto K, Matsukawa H, Ando Y, Suto H, Kondo A, Kishino T, Oshima M, Suzuki Y, Okano K
Experimental and Therapeutic Medicine 2025
The activity of glyoxylase 1 is regulated by glucose-responsive phosphorylation on Tyr136
F Cortizo, D Pfaff, A Wirth, A Schlotterer, R Medert, J Morgenstern, T Weber, H Hammes, T Fleming, P Nawroth, M Freichel, A Teleman
Molecular Metabolism 2022
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi A, Laubner K, Zhou Q, Hug MJ, Seufert J
Molecular Metabolism 2022
miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
Li H, Song D, Liu Q, Li L, Sun X, Guo J, Li D, Li P
Molecular Medicine 2022
Heart failure in diabetes
S Jankauskas, U Kansakar, F Varzideh, S Wilson, P Mone, A Lombardi, J Gambardella, G Santulli
Metabolism 2021
Streptozotocin‐Induced Diabetic Models in Mice and Rats
BL Furman
2021
Heart failure in diabetes
SS Jankauskas, U Kansakar, F Varzideh, S Wilson, P Mone, A Lombardi, J Gambardella, G Santulli
Metabolism 2021
Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
D Pirri, M Fragiadaki, PC Evans
Bioscience Reports 2020
Regulatory Effects of O-GlcNAcylation in Vascular Smooth Muscle Cells on Diabetic Vasculopathy
CH Byon, SW Kim
Journal of Lipid and Atherosclerosis 2020
Peroral administration of beauverolides allows their transport into the peripheral blood and urine
P Heneberg, A Jegorov, P Šimek
CYTA-J FOOD 2020
Ameliorative and Preventive Effects of Metformin, Nigella sativa, Punica granatum and Zingeber officinale on Bone Damage and Infections Caused by Diabetes mellitus in Animal Model
NA Jalaud
J PURE APPL MICROBIO 2019
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr −/− type 1 diabetic mice
A Al-Sharea, AJ Murphy, LA Huggins, Y Hu, IJ Goldberg, PR Nagareddy
Atherosclerosis 2018
Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis
, LH Zhong, A Huang, A Deng, GH Werstuck
Metabolomics 2018
The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production
H Alkhalidy, W Moore, Y Wang, J Luo, R McMillan, W Zhen, K Zhou, D Liu
Molecules (Basel, Switzerland) 2018
Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
B Giri, S Dey, T Das, M Sarkar, J Banerjee, SK Dash
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2018
Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes
M Tsujita, MA Hossain, R Lu, T Tsuboi, K Okumura-Noji, S Yokoyama
Journal of Atherosclerosis and Thrombosis 2017
A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans
S Nath, SK Ghosh, Y Choudhury
Journal of Pharmacological and Toxicological Methods 2017
Dietary glutamine supplementation enhances endothelial progenitor cell mobilization in streptozotocin-induced diabetic mice subjected to limb ischemia
ST Su, CL Yeh, YC Hou, MH Pai, SL Yeh
The Journal of Nutritional Biochemistry 2017
A Hepatic GAbp-AMPK Axis Links Inflammatory Signaling to Systemic Vascular Damage
K Niopek, BE Üstünel, S Seitz, M Sakurai, A Zota, F Mattijssen, X Wang, T Sijmonsma, Y Feuchter, AM Gail, B Leuchs, D Niopek, O Staufer, M Brune, C Sticht, N Gretz, K Müller-Decker, HP Hammes, P Nawroth, T Fleming, MD Conkright, M Blüher, A Zeigerer, S Herzig, MB Diaz
Cell Reports 2017
Increasing Atherosclerosis in Streptozotocin-Induced Diabetes into Four Groups of Mice
K Ritarwan, A Lelo, YS Pane, N Nerdy
Open Access Macedonian Journal of Medical Sciences 2017
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations
CC Wang, CN Hess, WR Hiatt, AB Goldfine
Circulation 2016
Large animal models of cardiovascular disease: Cardiovascular Disease Models
HG Tsang, NA Rashdan, CB Whitelaw, BM Corcoran, KM Summers, VE MacRae
Cell Biochemistry and Function 2016
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
M von Scheidt, Y Zhao, Z Kurt, C Pan, L Zeng, X Yang, H Schunkert, AJ Lusis
Cell Metabolism 2016
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
S Gargiulo, M Gramanzini, M Mancini
International journal of molecular sciences 2016
Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice
J Peng, K Hui, C Hao, Z Peng, QX Gao, Q Jin, G Lei, J Min, Z Qi, C Bo, QN Dong, ZH Bing, XY Jia, DL Fu
Connective Tissue Research 2016
A novel organ culture model of aorta for vascular calcification
T Akiyoshi, H Ota, K Iijima, BK Son, T Kahyo, M Setou, S Ogawa, Y Ouchi, M Akishita
Atherosclerosis 2016
Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches
SE Heinonen, G Genové, E Bengtsson, T Hübschle, L Åkesson, K Hiss, A Benardeau, S Ylä-Herttuala, AC Jönsson-Rylander, MF Gomez
Journal of Diabetes Research 2015
Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy
DA Kubli, ÅB Gustafsson
Antioxidants & Redox Signaling 2015
Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs
RH Al-Mashhadi, MM Bjørklund, MB Mortensen, C Christoffersen, T Larsen, E Falk, JF Bentzon
Diabetologia 2015
Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture: Figure 1
KE Bornfeldt
Diabetes 2015
Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
GP Chen, XQ Zhang, T Wu, L Li, J Han, CQ Du
Journal of Diabetes Research 2015
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition 2015
Current Protocols in Pharmacology: Streptozotocin-Induced Diabetic Models
BL Furman
Current Protocols in Pharmacology: Streptozotocin-Induced Diabetic Models 2015
Atherosclerosis: Risks, Mechanisms, and Therapies
HJ Pownall, C Rosales, BK Gillard, AM Gotto
Atherosclerosis: Risks, Mechanisms, and Therapies 2015
Effect of aqueous extract of Annona muricata seed on atherogenicity in streptozotocin-induced diabetic rats
EO Agbai, CJ Njoku, CO Nwanegwo, A Nwafor
AFR J PHARM PHARMACO 2015
2013 Russell Ross Memorial Lecture in Vascular Biology: Cellular and Molecular Mechanisms of Diabetes Mellitus-Accelerated Atherosclerosis
KE Bornfeldt
Arteriosclerosis, thrombosis, and vascular biology 2014
Genetic determinants of atherosclerosis, obesity, and energy balance in consomic mice
SH Spiezio, LM Amon, TS McMillen, CM Vick, BA Houston, M Caldwell, K Ogimoto, GJ Morton, EA Kirk, MW Schwartz, JH Nadeau, RC LeBoeuf
Mammalian Genome 2014
Differential MMP-9 activity in CD34+progenitor cell-derived foam cells from diabetic and normoglycemic patients
JU Schmohl, K Daub, SN von Ungern-Sternberg, S Lindemann, T Schönberger, T Geisler, M Gawaz, P Seizer
Herz 2013
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
DE Venegas-Pino, N Banko, MI Khan, Y Shi, GH Werstuck
Journal of visualized experiments : JoVE 2013
Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling
TS McMillen, E Minami, RC Leboeuf
Nutrition and Diabetes 2013
Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose
LR James, C Le, H Doherty, HS Kim, N Maeda, JC Dussaule
PloS one 2013
PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress
Y Wu, H Zhou, K Wu, S Lee, R Li, X Liu
Antioxidants & Redox Signaling 2013
Mechanisms of Diabetic Complications
JM Forbes, ME Cooper
Physiological reviews 2013
Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways
JS Chen, YH Chen, PH Huang, HY Tsai, YL Chen, SJ Lin, JW Chen
Cardiovascular Diabetology 2012
AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics
P Mocharla, S Briand, G Giannotti, C Dorries, P Jakob, F Paneni, T Luscher, U Landmesser
Blood 2012
Insulin Resistance, Hyperglycemia, and Atherosclerosis
KE Bornfeldt, I Tabas
Cell Metabolism 2011
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury
N Adhikari, DL Basi, M Carlson, A Mariash, Z Hong, U Lehman, S Mullegama, EK Weir, JL Hall
Arteriosclerosis, thrombosis, and vascular biology 2011
Painless Skin Electroporation as a Novel Way for Insulin Delivery
TW Wong, TY Chen, CC Huang, JC Tsai, SW Hui
Diabetes Technology & Therapeutics 2011
Salutary Effect of Cassia auriculata L. Leaves on Hyperglycemia-Induced Atherosclerotic Environment in Streptozotocin Rats
S Gupta, SB Sharma, UR Singh, SK Bansal
Cardiovascular Toxicology 2011
Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE−/− mice
DR Beriault, S Sharma, Y Shi, MI Khan, GH Werstuck
Atherosclerosis 2011
In vivo bioluminescence imaging of inducible nitric oxide synthase gene expression in vascular inflammation
M Terashima, S Ehara, E Yang, H Kosuge, PS Tsao, T Quertermous, CH Contag, MV McConnell
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011
Role of diabetes, hypertension, and cigarette smoking on atherosclerosis
RK Mathur
Journal of cardiovascular disease research 2010
Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes
S Zervou, YF Wang, A Laiho, A Gyenesei, L Kytömäki, R Hermann, S Abouna, D Epstein, S Pelengaris, M Khan
Diabetologia 2010
Macrovascular complications of diabetes in atherosclerosisprone mice
LA Johnson, N Maeda
Expert Review of Endocrinology & Metabolism 2010
Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice
JJ Manning-Tobin, KJ Moore, TA Seimon, SA Bell, M Sharuk, JI Alvarez-Leite, MP de Winther, I Tabas, MW Freeman
Arteriosclerosis, thrombosis, and vascular biology 2009
Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus
ED Falco, D Avitabile, P Totta, S Straino, F Spallotta, C Cencioni, AR Torella, R Rizzi, D Porcelli, A Zacheo, LD Vito, G Pompilio, M Napolitano, G Melillo, MC Capogrossi, M Pesce
Journal of Cellular and Molecular Medicine 2009
Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis
AJ Bowes, MI Khan, Y Shi, L Robertson, GH Werstuck
The American Journal of Pathology 2009
Evidence Supporting a Role for Endoplasmic Reticulum Stress in the Development of Atherosclerosis in a Hyperglycaemic Mouse Model
MI Khan, BA Pichna, Y Shi, AJ Bowes, GH Werstuck
Antioxidants & Redox Signaling 2009
Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes
IJ Goldberg, Y Hu, HL Noh, J Wei, LA Huggins, MG Rackmill, H Hamai, BN Reid, WS Blaner, LS Huang
Diabetes 2008
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
G Spinetti, N Kraenkel, C Emanueli, P Madeddu
Cardiovascular Research 2008
Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes
DK Arulmozhi, R Kurian, SL Bodhankar, A Veeranjaneyulu
Journal of Pharmacy and Pharmacology 2008
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents
J Zhou, RJ Martin, RT Tulley, AM Raggio, KL McCutcheon, L Shen, SC Danna, S Tripathy, M Hegsted, MJ Keenan
American journal of physiology. Endocrinology and metabolism 2008
Mouse Models for Studies of Cardiovascular Complications of Type 1 Diabetes
X Shen, KE Bornfeldt
Annals of the New York Academy of Sciences 2007
The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats
M Kanter, MF Altan, S Donmez, A Ocakci, ME Kartal
Cell Biochemistry and Function 2007
Diabetic atherosclerosis mouse models
KK Wu, Y Huan
Atherosclerosis 2007
Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats
MF Altan, M Kanter, S Donmez, ME Kartal, S Buyukbas
Acta Histochemica 2007
Regulation of Vascular Proteoglycan Synthesis by Metabolic Factors Associated with Diabetes:
P Wilson, K Drennon, LR Tannock
Journal of Investigative Medicine 2007
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
J Benton, A Powers, L Eiselein, R Fitch, D Wilson, AC Villablanca, JC Rutledge
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2007
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
T Shoji, H Koyama, T Morioka, S Tanaka, A Kizu, K Motoyama, K Mori, S Fukumoto, A Shioi, N Shimogaito, M Takeuchi, Y Yamamoto, H Yonekura, H Yamamoto, Y Nishizawa
Diabetes 2006
Current Protocols in Pharmacology
JP Renninger
Current Protocols in Pharmacology 2006
Plasminogen Activator Inhibitor-1 Deficiency Has Renal Benefits but Some Adverse Systemic Consequences in Diabetic Mice
SJ Collins, SL Alexander, JM Lopez-Guisa, X Cai, R Maruvada, SC Chua, G Zhang, DM Okamura, S Matsuo, AA Eddy
Nephron Experimental Nephrology 2006
Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium
D Popov, M Simionescu
Archives Of Physiology And Biochemistry 2006
Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?
C Renard, EV Obberghen
Diabetes & Metabolism 2006
Loss of scavenger receptor mediated lipid uptake via SR-A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
Kathryn J. Moore, Vidya V. Kunjathoor, Stephanie L. Koehn, Jennifer J. Manning, Anita A. Tseng, Jessica M. Silver, Mary McKee and Mason W. Freeman
Journal of Clinical Investigation 2005
Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice
JA Berti, AG Salerno, EJ Bighetti, AC Casquero, AC Boschero, HC Oliveira
APMIS 2005
Development of atherosclerosis in the diabetic BALB/c mice
P Otero, B Bonet, E Herrera, A Rabano
Atherosclerosis 2005
Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor
KK Wu, TJ Wu, J Chin, LJ Mitnaul, M Hernandez, TQ Cai, N Ren, MG Waters, SD Wright, K Cheng
Atherosclerosis 2005
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
GH Werstuck, MI Khan, G Femia, AJ Kim, V Tedesco, B Trigatti, Y Shi
Diabetes 2005
Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin
D Pighin, L Karabatas, C Pastorale, E Dascal, C Carbone, A Chicco, YB Lombardo, JC Basabe
Journal of applied physiology 2005
Diabetes and Diabetes-Associated Lipid Abnormalities Have Distinct Effects on Initiation and Progression of Atherosclerotic Lesions
Catherine B. Renard, Farah Kramer, Fredrik Johansson, Najib Lamharzi, Lisa R. Tannock, Matthias G. von Herrath, Alan Chait, Karin E. Bornfeldt
Journal of Clinical Investigation 2004
Epidermal cells accelerate the restoration of the blood flow in diabetic ischemic limbs
C Jiao, S Bronner, KL Mercer, DD Sheriff, GC Schatteman, M Dunnwald
Journal of cell science 2004
Cellular and Molecular Mechanisms of Atherosclerosis with Mouse Models
R Ohashi, H Mu, Q Yao, C Chen
Trends in Cardiovascular Medicine 2004
Why does diabetes increase atherosclerosis? I don’t know!
IJ Goldberg
Journal of Clinical Investigation 2004
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
KS Michelsen, TM Doherty, PK Shah, M Arditi
Journal of immunology (Baltimore, Md. : 1950) 2004
Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice
IJ Goldberg, A Isaacs, E Sehayek, JL Breslow, LS Huang
Atherosclerosis 2004
Repeated Streptozotocin Injections Cause Early Onset of Glomerulosclerosis in Mice
S MIZUNO, J WEN, Y MIZUNO-HORIKAWA
Experimental Animals 2004
How the Davis 2.36 ATA wound healing enhancement treatment table was established
L Park, KG Raman, KJ Lee, Y Lu, LJ Ferran, WS Chow, D Stern, AM Schmidt
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2004
How the Davis 2.36 ATA wound healing enhancement treatment table was established
L Park, KG Raman, KJ Lee, Y Lu, LJ Ferran, WS Chow, D Stern, AM Schmidt
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2004
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
KS Michelsen, TM Doherty, PK Shah, M Arditi
Journal of immunology (Baltimore, Md. : 1950) 2004
Hepatic Gene Expression Profiling of Streptozotocin-Induced Diabetes
JM Dhahbi, PL Mote, SX Cao, SR Spindler
Diabetes Technology & Therapeutics 2003
Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity
SA Schreyer, TC Lystig, CM Vick, RC LeBoeuf
Atherosclerosis 2003
Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy
SM Hammad, L Powell-Braxton, JD Otvos, L Eldridge, W Won, TJ Lyons
Metabolism 2003
Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice
M Potier, M Karl, SJ Elliot, GE Striker, LJ Striker
American journal of physiology. Endocrinology and metabolism 2003
Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation
H Lu, D Kraut, LC Gerstenfeld, DT Graves
Endocrinology 2003
Atlas of Atherosclerosis
PW Wilson
2003
Hepatic Expression of Microsomal Triglyceride Transfer Protein and In Vivo Secretion of Triglyceride-Rich Lipoproteins Are Increased in Obese Diabetic Mice
ED Bartels, M Lauritsen, LB Nielsen
Diabetes 2002
Overexpression of Apolipoprotein B in the Heart Impedes Cardiac Triglyceride Accumulation and Development of Cardiac Dysfunction in Diabetic Mice
LB Nielsen, ED Bartels, E Bollano
The Journal of biological chemistry 2002
Accumulation of Biglycan and Perlecan, but Not Versican, in Lesions of Murine Models of Atherosclerosis
VV Kunjathoor, DS Chiu, KD OBrien, RC LeBoeuf
Arteriosclerosis, thrombosis, and vascular biology 2002
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice
Y Kako, M Massé, LS Huang, AR Tall, IJ Goldberg
Journal of lipid research 2002
Iron overload diminishes atherosclerosis in apolipoprotein e-deficient mice
Elizabeth A. Kirk, Jay W. Heinecke, and Renee C. LeBoeuf
Journal of Clinical Investigation 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski, JB Boord, K Maeda, VR Babaev, KT Uysal, MA Morgan, RA Parker, J Suttles, S Fazio, GS Hotamisligil, MF Linton
Nature Medicine 2001
Genetic Modifiers of Atherosclerosis in Mice
JD Smith, HM Dansky, JL Breslow
Annals of the New York Academy of Sciences 2001
Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis
P Keren, J George, G Keren, D Harats
Atherosclerosis 2001
CD34−Blood-Derived Human Endothelial Cell Progenitors
M Harraz, C Jiao, HD Hanlon, RS Hartley, GC Schatteman
Stem Cells 2001
Cardiovascular structure and function in baboons with Type 1 diabetes — a transvenous ultrasound study
U Premawardhana, MR Adams, A Birrell, DK Yue, DS Celermajer
Journal of Diabetes and its Complications 2001
The lipid-lowering effect of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara Benth. in mice fed on high-fat diet
R M Silva, F A Santos, V S Rao, M A Maciel, A C Pinto
The Journal of pharmacy and pharmacology 2001
Delayed catabolism of apoB48 lipoproteins in streptozotocin-treated mice: evidence that diabetes leads to a selective alteration in the heparan sulfate proteoglycan pathway of chylomicron remnant degradation
Tetsu Ebara, Karin Conde, Yuko Kako, Yan Xu, Rajasekhar Ramakrishnan, Ira J. Goldberg, Neil S. Shachter
Journal of Clinical Investigation 2000
Blood-derived angioblasts accelerate blood flow restoration in diabetic mice
Gina C. Schatteman, Heather D. Hanlon, Chunhua Jiao, Sherry G. Dodds, Barbara A. Christy
Journal of Clinical Investigation 2000
Aortic Atheromatous Lesions Developed in APA Hamsters with Streptozotocin induced Diabetes: A New Animal Model for Diabetic Atherosclerosis. 1. Histopathological Studies
J YAMANOUCHI, E NISHIDA, S ITAGAKI, S KAWAMURA, K DOI, Y YOSHIKAWA
Experimental Animals 2000
Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries
C Agardh
Journal of Diabetes and its Complications 2000
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice
EA Kirk, MC Dinauer, H Rosen, A Chait, JW Heinecke, RC LeBoeuf
Arteriosclerosis, thrombosis, and vascular biology 2000
Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene
K Reue, P Xu, XP Wang, BG Slavin
Journal of lipid research 2000
Hyperglycemia Inhibits Vascular Smooth Muscle Cell Apoptosis Through a Protein Kinase C–Dependent Pathway
JL Hall, CM Matter, X Wang, GH Gibbons
Circulation research 2000
Genetic modifiers of atherosclerosis in mice.
Knowles JW, Maeda N
Arteriosclerosis, thrombosis, and vascular biology 2000
Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol
J Tse, B Martin-McNaulty, M Halks-Miller, K Kauser, V DelVecchio, R Vergona, ME Sullivan, GM Rubanyi
Atherosclerosis 1999
Emerging therapeutic targets in diabetic vascular disease
AM Schmidt, DM Stern
Expert Opinion on Therapeutic Targets 1999
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia
A Ceriello, N Bortolotti, E Motz, C Pieri, M Marra, L Tonutti, S Lizzio, F Feletto, B Catone, C Taboga
Metabolism 1999
Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: Inhibition by estradiol in normal and high glucose cultures
R Xu, JA Morales, R Muniyappa, DF Skafar, JL Ram, JR Sowers
Life Sciences 1999
Activation of Receptor for Advanced Glycation End Products: A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis
AM Schmidt, SD Yan, JL Wautier, D Stern
Circulation research 1999
Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis
Y Kako, LS Huang, J Yang, T Katopodis, R Ramakrishnan, IJ Goldberg
Journal of lipid research 1999
Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J
JL Mu, JK Naggert, KL Svenson, GB Collin, JH Kim, C McFarland, PM Nishina, DM Levine, KJ Williams, B Paigen
Journal of lipid research 1999
C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis
SA Schreyer, DL Wilson, RC LeBoeuf
Atherosclerosis 1998
Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
K Ichikawa, M Yoshinari, M Iwase, M Wakisaka, Y Doi, K Iino, M Yamamoto, M Fujishima
Atherosclerosis 1998
Cardiovascular risk continuum: implications of insulin resistance and diabetes
WA Hsueh, RE Law
The American Journal of Medicine 1998
Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but not LDL Receptor–Deficient Mice
EA Kirk, P Sutherland, SA Wang, A Chait, RC LeBoeuf
The Journal of nutrition 1998
Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse
RS Crawford, EA Kirk, ME Rosenfeld, RC LeBoeuf, A Chait
Arteriosclerosis, thrombosis, and vascular biology 1998
Interaction of Diabetes and Hypertension on Determinants of Endothelial Adhesiveness
PS Tsao, J Niebauer, R Buitrago, PS Lin, B Wang, JP Cooke, YI Chen, GM Reaven
Arteriosclerosis, thrombosis, and vascular biology 1998
Absence of P-selectin delays fatty streak formation in mice
RC Johnson, SM Chapman, ZM Dong, JM Ordovas, TN Mayadas, J Herz, RO Hynes, EJ Schaefer, DD Wagner
Journal of Clinical Investigation 1997
Determinants of coronary vascular disease in patients with type ii diabetes mellitus and their therapeutic implications
DJ Schneider, BE Sobel
Clinical Cardiology 1997
Reduced Myocardial Flow Reserve in Non–Insulin-Dependent Diabetes Mellitus
IY MD, SM MD, TO MD, KY MD, JN MD, YS MD, MO MD
Journal of the American College of Cardiology 1997
Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55
SA Schreyer, JJ Peschon, RC LeBoeuf
The Journal of biological chemistry 1996

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 1 patents
73 readers on Mendeley
See more details